Evelyn Flynn

13.9k total citations · 3 hit papers
66 papers, 11.4k citations indexed

About

Evelyn Flynn is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Evelyn Flynn has authored 66 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Surgery. Recurrent topics in Evelyn Flynn's work include Angiogenesis and VEGF in Cancer (16 papers), Cell Adhesion Molecules Research (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Evelyn Flynn is often cited by papers focused on Angiogenesis and VEGF in Cancer (16 papers), Cell Adhesion Molecules Research (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Evelyn Flynn collaborates with scholars based in United States, Germany and Australia. Evelyn Flynn's co-authors include Judah Folkman, Robert J. D’Amato, Michael Loughnan, William S. Lane, Yuen Shing, George Vasios, Michael S. O’Reilly, James R. Birkhead, Thomas Boehm and Naomi Fukai and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Evelyn Flynn

66 papers receiving 11.0k citations

Hit Papers

Endostatin: An Endogenous Inhibitor of Angiogenesis and T... 1994 2026 2004 2015 1997 1994 1999 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
    1997 3.7k citations Evelyn Flynn, Judah Folkman et al. profile →
  2. Thalidomide is an inhibitor of angiogenesis.
    1994 2.0k citations Robert J. D’Amato, Evelyn Flynn et al. profile →
  3. Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice
    1999 558 citations Evelyn Flynn, Judah Folkman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evelyn Flynn United States 36 6.8k 3.1k 2.5k 1.3k 1.1k 66 11.4k
Gerald McMahon United States 45 7.0k 1.0× 2.9k 0.9× 3.1k 1.2× 946 0.7× 1.4k 1.2× 77 11.8k
Menashe Bar‐Eli United States 68 6.9k 1.0× 2.6k 0.8× 4.2k 1.7× 1.1k 0.8× 1.0k 0.9× 186 12.0k
Raffaella Giavazzi Italy 57 6.2k 0.9× 3.4k 1.1× 4.0k 1.6× 834 0.6× 944 0.8× 232 11.4k
Wun-Jing Kuang United States 12 5.8k 0.8× 1.9k 0.6× 2.5k 1.0× 1.7k 1.3× 1.2k 1.0× 12 11.7k
Yuen Shing United States 29 7.1k 1.0× 3.3k 1.0× 1.9k 0.8× 651 0.5× 859 0.8× 57 10.4k
Olga V. Volpert United States 57 8.4k 1.2× 4.0k 1.3× 2.3k 0.9× 553 0.4× 878 0.8× 107 12.5k
Reuven Reich Israel 59 5.4k 0.8× 3.4k 1.1× 3.0k 1.2× 993 0.7× 863 0.8× 202 11.2k
Gary E. Gallick United States 67 7.7k 1.1× 2.9k 0.9× 6.0k 2.4× 1.2k 0.9× 2.0k 1.7× 202 13.7k
J Folkman United States 21 6.2k 0.9× 3.0k 1.0× 2.6k 1.0× 449 0.3× 1.2k 1.0× 30 10.3k
Rama Khokha Canada 73 7.3k 1.1× 5.9k 1.9× 6.4k 2.6× 1.3k 0.9× 1.5k 1.3× 168 15.6k

Countries citing papers authored by Evelyn Flynn

Since Specialization
Citations

This map shows the geographic impact of Evelyn Flynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evelyn Flynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evelyn Flynn more than expected).

Fields of papers citing papers by Evelyn Flynn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evelyn Flynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evelyn Flynn. The network helps show where Evelyn Flynn may publish in the future.

Co-authorship network of co-authors of Evelyn Flynn

This figure shows the co-authorship network connecting the top 25 collaborators of Evelyn Flynn. A scholar is included among the top collaborators of Evelyn Flynn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evelyn Flynn. Evelyn Flynn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wedel, Johannes, Tatsuichiro Seto, Evelyn Flynn, et al.. (2019). T Cell–Specific Adaptor Protein Regulates Mitochondrial Function and CD4+ T Regulatory Cell Activity In Vivo following Transplantation. The Journal of Immunology. 203(8). 2328–2338. 8 indexed citations
3.
Shapiro, Frederic & Evelyn Flynn. (2015). Structural differences in epiphyseal and physeal hypertrophic chondrocytes. BoneKEy Reports. 4. 663–663. 2 indexed citations
4.
5.
Bourke, David, Dara A. Stanley, Jens Dauber, et al.. (2013). Response of farmland biodiversity to the introduction of bioenergy crops: effects of local factors and surrounding landscape context. GCB Bioenergy. 6(3). 275–289. 42 indexed citations
6.
Basu, Aninda, Tao Liu, Pallavi Banerjee, et al.. (2012). Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression. Cancer Letters. 321(2). 179–186. 11 indexed citations
7.
Datta, Dipak, Alan G. Contreras, Aninda Basu, et al.. (2009). Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer Cells. Cancer Research. 69(23). 8902–8909. 54 indexed citations
8.
Basu, Aninda, Alan G. Contreras, Dipak Datta, et al.. (2008). Overexpression of Vascular Endothelial Growth Factor and the Development of Post-Transplantation Cancer. Cancer Research. 68(14). 5689–5698. 56 indexed citations
9.
Dormond, Olivier, Alan G. Contreras, Esther Meijer, et al.. (2008). CD40-Induced Signaling in Human Endothelial Cells Results in mTORC2- and Akt-Dependent Expression of Vascular Endothelial Growth Factor In Vitro and In Vivo. The Journal of Immunology. 181(11). 8088–8095. 44 indexed citations
10.
Kim, Sendia, Sang Hong Lee, Arin K. Greene, et al.. (2007). Inhibition of Intra-Abdominal Adhesion Formation With the Angiogenesis Inhibitor Sunitinib. Journal of Surgical Research. 149(1). 115–119. 27 indexed citations
11.
Hašková, Zdenka, Atsushi Izawa, Alan G. Contreras, et al.. (2007). Organ-Specific Differences in the Function of MCP-1 and CXCR3 During Cardiac and Skin Allograft Rejection. Transplantation. 83(12). 1595–1601. 20 indexed citations
12.
Naumov, George N., Elise R. Bender, David Zurakowski, et al.. (2006). A Model of Human Tumor Dormancy: An Angiogenic Switch From the Nonangiogenic Phenotype. JNCI Journal of the National Cancer Institute. 98(5). 316–325. 308 indexed citations
13.
Tsuchihashi, Sei-ichiro, Bibo Ke, Fady M. Kaldas, et al.. (2006). Vascular Endothelial Growth Factor Antagonist Modulates Leukocyte Trafficking and Protects Mouse Livers against Ischemia/Reperfusion Injury. American Journal Of Pathology. 168(2). 695–705. 46 indexed citations
14.
Greene, Arin K., Ian P.J. Alwayn, Vânia Nosé, et al.. (2005). Prevention of Intra-abdominal Adhesions Using the Antiangiogenic COX-2 Inhibitor Celecoxib. Annals of Surgery. 242(1). 140–146. 81 indexed citations
15.
Kisker, O., Shinya Onizuka, Christian M. Becker, et al.. (2003). Vitamin D Binding Protein-Macrophage Activating Factor (DBP-maf) Inhibits Angiogenesis and Tumor Growth in Mice. Neoplasia. 5(1). 32–40. 100 indexed citations
16.
Achilles, E., Ariel Fernández, Elizabeth N. Allred, et al.. (2001). Heterogeneity of Angiogenic Activity in a Human Liposarcoma: a Proposed Mechanism for "No Take" of Human Tumors in Mice. JNCI Journal of the National Cancer Institute. 93(14). 1075–1081. 71 indexed citations
17.
Voest, Emile E., et al.. (1995). The discovery of new inhibitors of angiogenesis using an improved mouse corneal neovascularization model. Investigative Ophthalmology & Visual Science. 36(4). 94. 2 indexed citations
18.
Flynn, Evelyn, Joel Schwartz, & Gerald Shklar. (1991). Sequential mast cell infiltration and degranulation during experimental carcinogenesis. Journal of Cancer Research and Clinical Oncology. 117(2). 115–122. 43 indexed citations
19.
Schwartz, Joel, et al.. (1990). The Administration of Beta Carotene to Prevent and Regress Oral Carcinoma in the Hamster Cheek Pouch and the Associated Enhancement of the Immune Response. Advances in experimental medicine and biology. 262. 77–93. 25 indexed citations
20.
Gilchrest, Barbara A., George Szabó, Evelyn Flynn, & Robert M. Goldwyn. (1983). Chronologic and Actinically Induced Aging in Human Facial Skin.. Journal of Investigative Dermatology. 80(s6). 81s–85s. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerald McMahon Breakdown of academic impact, for papers by Menashe Bar‐Eli Breakdown of academic impact, for papers by Raffaella Giavazzi Breakdown of academic impact, for papers by Wun-Jing Kuang Breakdown of academic impact, for papers by Yuen Shing Breakdown of academic impact, for papers by Olga V. Volpert Breakdown of academic impact, for papers by Reuven Reich Breakdown of academic impact, for papers by Gary E. Gallick Breakdown of academic impact, for papers by J Folkman Breakdown of academic impact, for papers by Rama Khokha
Rankless by CCL
2026